Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
GoDaddy
GDDY
$13B
| $545M | 0.31% |
7,432,425
+29,129
| +0.4% | +$2.09M |
|
77
CME Group
CME
$92.5B
| $540M | 0.3% |
3,323,689
-198,335
| -6% | -$35.6M |
|
78
CSX Corp
CSX
$96.1B
| $515M | 0.29% |
22,154,892
-43,365
| -0.2% | -$959K |
|
79
ON Semiconductor
ON
$34B
| $513M | 0.29% |
25,877,541
-5,536,066
| -18% | -$90.2M |
|
80
Lamar Advertising Co
LAMR
$16.5B
| $509M | 0.29% |
7,629,955
-64,204
| -0.8% | -$3.92M |
|
81
Air Products & Chemicals
APD
$65.2B
| $509M | 0.29% |
2,107,313
-49,642
| -2% | -$11.3M |
|
82
American Express
AXP
$228B
| $501M | 0.28% |
5,260,753
+320,432
| +6% | +$29.5M |
|
83
ICU Medical
ICUI
$4.02B
| $486M | 0.27% |
2,638,409
-130,356
| -5% | -$25.9M |
|
84
Edwards Lifesciences
EW
$48.3B
| $472M | 0.27% |
6,836,193
-43,440
| -0.6% | -$3.09M |
|
85
Crown Holdings
CCK
$12.8B
| $467M | 0.26% |
7,175,874
+73,808
| +1% | +$4.64M |
|
86
VICI Properties
VICI
$29.6B
| $465M | 0.26% |
23,049,487
+8,832,904
| +62% | +$162M |
|
|
HZNP
87
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $465M | 0.26% |
8,357,524
+1,674,602
| +25% | +$71.6M |
|
88
Johnson & Johnson
JNJ
$643B
| $451M | 0.25% |
3,208,927
-312,067
| -9% | -$45.5M |
|
89
Gilead Sciences
GILD
$163B
| $451M | 0.25% |
5,855,657
+63,922
| +1% | +$4.9M |
|
90
Hasbro
HAS
$12.7B
| $447M | 0.25% |
5,967,593
-34,722
| -0.6% | -$2.51M |
|
91
General Dynamics
GD
$106B
| $447M | 0.25% |
2,989,044
+661,469
| +28% | +$93.4M |
|
92
Morgan Stanley
MS
$336B
| $445M | 0.25% |
9,206,381
+4,087,029
| +80% | +$172M |
|
93
Medtronic
MDT
$109B
| $444M | 0.25% |
4,843,817
+398,438
| +9% | +$38.2M |
|
94
ASML
ASML
$633B
| $441M | 0.25% |
1,198,142
-1,263
| -0.1% | -$396K |
|
95
Teledyne Technologies
TDY
$30.1B
| $422M | 0.24% |
1,355,815
-173,315
| -11% | -$57M |
|
96
Willis Towers Watson
WTW
$28.5B
| $421M | 0.24% |
2,139,256
+25,671
| +1% | +$4.91M |
|
97
Broadcom
AVGO
$1.82T
| $421M | 0.24% |
13,327,930
+815,940
| +7% | +$22.8M |
|
98
Amdocs
DOX
$5.71B
| $416M | 0.23% |
6,837,224
-33,812
| -0.5% | -$2.09M |
|
99
Novartis
NVS
$297B
| $409M | 0.23% |
4,687,648
+228,395
| +5% | +$19.7M |
|
100
Centene
CNC
$31.9B
| $407M | 0.23% |
6,405,168
-126,868
| -2% | -$8.26M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.